Compare ATRA & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATRA | DOMH |
|---|---|---|
| Founded | 2012 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.2M | 73.3M |
| IPO Year | 2014 | 2010 |
| Metric | ATRA | DOMH |
|---|---|---|
| Price | $9.00 | $2.40 |
| Analyst Decision | Sell | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | 44.7K | ★ 177.8K |
| Earning Date | 05-13-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 23.45% |
| EPS Growth | ★ 122.52 | 34.03 |
| EPS | ★ N/A | N/A |
| Revenue | $120,772,000.00 | ★ $123,104,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 578.41 |
| 52 Week Low | $3.92 | $2.19 |
| 52 Week High | $19.15 | $8.40 |
| Indicator | ATRA | DOMH |
|---|---|---|
| Relative Strength Index (RSI) | 51.47 | 41.27 |
| Support Level | $9.03 | $2.29 |
| Resistance Level | $11.17 | $3.39 |
| Average True Range (ATR) | 0.66 | 0.19 |
| MACD | 0.08 | -0.01 |
| Stochastic Oscillator | 62.01 | 1.12 |
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.
Dominari Holdings Inc is a holding company that, through its various subsidiaries, is engaged in wealth management, investment banking, sales and trading, asset management, and insurance. In addition to capital investment, Dominari provides management support to the executive teams of its subsidiaries, helping them to operate efficiently and reduce costs under a streamlined infrastructure. The Company operates in two reportable business segments: Dominari Financial and Legacy AIkido, with the majority of revenue from Dominari Financial.